Details for New Drug Application (NDA): 016675
✉ Email this page to a colleague
NDA 016675 describes DECADRON-LA, which is a drug marketed by Merck and is included in one NDA. Additional details are available on the DECADRON-LA profile page.
The generic ingredient in DECADRON-LA is dexamethasone acetate. There are thirty-nine drug master file entries for this compound. Additional details are available on the dexamethasone acetate profile page.
The generic ingredient in DECADRON-LA is dexamethasone acetate. There are thirty-nine drug master file entries for this compound. Additional details are available on the dexamethasone acetate profile page.
Summary for 016675
| Tradename: | DECADRON-LA |
| Applicant: | Merck |
| Ingredient: | dexamethasone acetate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 8MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
